Trial Profile
Establishment of appropriate termination method of dexmedetomidine in pediatric patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 30 Jun 2019 Status changed from recruiting to completed.
- 31 Dec 2017 Planned number of patients changed from 50 to 60.
- 19 May 2016 New trial record